Leerink Partners analyst Daina Graybosch reiterated a Market Perform rating and $2.00 price target on Century Therapeutics (NASDAQ: IPSC).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments